Premium
The Novel p53‐Dependent Metastatic and Apoptotic Pathway Induced by Vitexin in Human Oral Cancer OC2 Cells
Author(s) -
Yang ShihHuang,
Liao PaoHsin,
Pan YaFang,
Chen ShiowLing,
Chou ShihShen,
Chou MingYung
Publication year - 2013
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.4841
Subject(s) - vitexin , mapk/erk pathway , cancer research , apoptosis , biology , signal transduction , cancer cell , gene knockdown , cancer , microbiology and biotechnology , biochemistry , flavonoid , antioxidant , genetics
Vitexin, identified as apigenin‐8‐C‐D‐glucopyranoside, a natural flavonoid compound found in certain herbs such as hawthorn herb, has been reported to exhibit anti‐oxidative, anti‐inflammatory, anti‐metastatic and antitumor properties. The aim of this study was to investigate the possible existence of p53‐dependent pathway underlying vitexin‐induced metastasis and apoptosis in human oral cancer cells, OC2 cells. Vitexin decreased cell viability significantly. Meanwhile, the expression of tumor suppressor p53 and a small group of its downstream genes, p21 WAF1 and Bax, were upregulated. The p53 inhibitor pifithrin‐α (PFT‐α) knockdown of the signaling of p53 led vitexin to lose its antitumor effect and inhibited the expression of p53 downstream genes, p21 WAF1 and Bax. Vitexin had anti‐metastatic potential accompanied with increasing plasminogen activator inhibitor 1 (PAI‐1) accumulation and decreasing matrix metalloproteinase‐2 expression. Our present study evidenced, by using p53 inhibitor PFT‐α, PAI‐1 and peroxisome proliferator‐activated receptor γ are downstream genes of p53 in vitexin‐induced signaling. MAPK inhibitor PD98059 decreased the OC2 cells viability significantly. The expression of p53 and its downstream genes p21 WAF1 and Bax were enhanced by blocking the activation of p42/p44 MAPK in response to treatment with vitexin. Moreover, p42/p44 MAPK played a negative role in p53‐dependent metastasis and apoptosis. We give evidence for the first time that the novel p53‐dependent metastatic and apoptotic pathway induced by vitexin in human oral cancer OC2 cells. Copyright © 2012 John Wiley & Sons, Ltd.